(Total Views: 798)
Posted On: 03/17/2022 1:56:27 PM
Post# of 153886
Dr. Ray Apr 11 mTNBC trial presentation, Nashville
details of N.G. Ray leronlimab breast cancer trial presentation AACR Annual Meeting April 11, 2022 1:30pm to 5:00pm, New Orleans, Section 35
Cytodyn presenting with
[] Creatv MicroTech, Inc. (Dr. Cha Mei Tang, Founder, President, and CEO cancer diagnostics)
leronlimab breast cancer presentation title:
CT156 / 24 - Changes in circulating tumor associated cells predicts progression free and overall survival in metastatic TNBC patients after induction of the anti-CCR5 drug leronlimab
presentation link:
https://www.abstractsonline.com/pp8/#!/10517/...tion/20627
Here is the prior, Aug 15, 2020 abstract:
https://aacrjournals.org/cancerres/article/80...nlimab-PRO
details of N.G. Ray leronlimab breast cancer trial presentation AACR Annual Meeting April 11, 2022 1:30pm to 5:00pm, New Orleans, Section 35
Cytodyn presenting with
[] Creatv MicroTech, Inc. (Dr. Cha Mei Tang, Founder, President, and CEO cancer diagnostics)
leronlimab breast cancer presentation title:
CT156 / 24 - Changes in circulating tumor associated cells predicts progression free and overall survival in metastatic TNBC patients after induction of the anti-CCR5 drug leronlimab
presentation link:
https://www.abstractsonline.com/pp8/#!/10517/...tion/20627
Here is the prior, Aug 15, 2020 abstract:
https://aacrjournals.org/cancerres/article/80...nlimab-PRO
(5)
(0)
